Comparison of zopiclone and flurazepam treatments in insomnia
β Scribed by Dr. Amarendra N. Singh; Jean Bourgouin
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 490 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
In this double-blind study the efficacy and safety of two doses (7.5 and 11.25 mg) of zopiclone were compared to that of flurazepam (30mg) in 60 insomniac patients divided into three groups. After an initial 4-day washout period, placebo was administered single-blind to all patients followed by 24 consecutive days of either one of the three drug levels. No significant difference was shown between the two zopiclone dosages at any time during the study for sleep efficacy and psychomotor performance. Compared to flurazepam, zopiclone was slightly less effective for sleep induction and sleep soundness variables. However, flurazepam was constantly worse than zopiclone for daytime performance. This study shows that both zopiclone dosages are shown to be active and safe in the treatment of insomnia, and exhibit a true advantage over flurazepam by its low incidence of residual effects.
π SIMILAR VOLUMES
Insomnia leads to disrupted sleep and daytime fatigue. Many people who have this disorder look to the medical profession for treatment; however, it has been demonstrated that psychological approaches are usually more efficacious over the long term. Furthermore, such interventions are safe, cost effe